IE000B9PQW54.SG VanEck Genomics and Healthcare Innovators UCITS ETF | IE000B9PQW54
Holdings & Portfolio Structure
Detailed breakdown of ETF components
ETF Concentration (Cumulative Weight)
Sector Distribution
Healthcare 94.40%
Unknown 5.58%
Industry Distribution
Biotechnology 41.59%
Diagnostics & Research 23.51%
Health Information Services 14.78%
Medical Devices 11.40%
Unknown 5.58%
Drug Manufacturers - Specialty & Generic 1.88%
Pharmaceutical Retailers 0.96%
Medical Instruments & Supplies 0.28%
Geographic Distribution
Loading TopoJSON...
All Holdings
Ticker | Name | Sector | Industry | Market Cap | Weight | P/E | Fwd P/E | Revenue Estimate | EPS Estimate |
|---|---|---|---|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Incorpor | Healthcare | Biotechnology | 106,51 Mrd. € | 7.83% | 28.35 | 22.40 | CY +8.71% CQ +8.77% NY +9.98% NQ +4.15% | CY +3.06% CQ +5.04% NY +12.40% NQ +1.38% |
| REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | Biotechnology | 60,46 Mrd. € | 7.76% | 16.02 | 12.01 | CY +10.67% CQ +4.06% NY +10.93% NQ +9.72% | CY +3.47% CQ -20.43% NY +3.38% NQ +28.76% |
| NTRA | Natera, Inc. | Healthcare | Diagnostics & Research | 32,98 Mrd. € | 7.12% | - | -1279.94 | CY +21.29% CQ +20.98% NY +18.99% NQ +5.01% | CY -12.42% CQ +27.84% NY +88.02% NQ +29.19% |
| DXCM | DexCom, Inc. | Healthcare | Medical Devices | 24,27 Mrd. € | 6.17% | 30.70 | 23.25 | CY +12.06% CQ +11.52% NY +11.54% NQ +3.42% | CY +23.87% CQ +26.45% NY +18.87% NQ +10.79% |
| VEEV | Veeva Systems Inc. | Healthcare | Health Information Services | 26,6 Mrd. € | 6.12% | 33.02 | 18.56 | CY +13.96% CQ +14.74% NY +12.08% NQ +1.41% | CY +11.88% CQ +11.67% NY +10.72% NQ +2.83% |
| MRNA | Moderna, Inc. | Healthcare | Biotechnology | 18,86 Mrd. € | 5.87% | - | -12.90 | CY +7.77% CQ -27.40% NY +21.79% NQ +778.73% | CY -19.26% CQ +3.33% NY +45.13% NQ +43.37% |
| ILMN | Illumina, Inc. | Healthcare | Diagnostics & Research | 25,82 Mrd. € | 5.14% | 35.35 | 32.71 | CY +5.24% CQ +6.78% NY +5.70% NQ +1.09% | CY +8.04% CQ +3.10% NY +13.46% NQ +10.73% |
| ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | Biotechnology | 31,9 Mrd. € | 4.96% | 67.60 | 20.22 | CY +51.13% CQ +70.82% NY +29.04% NQ +11.86% | CY +85.50% CQ +573.48% NY +42.62% NQ +11.87% |
| GH | Guardant Health, Inc. | Healthcare | Diagnostics & Research | 17,17 Mrd. € | 4.84% | - | -340.10 | CY +33.85% CQ +35.48% NY +30.50% NQ +7.75% | CY +23.38% CQ +11.46% NY +68.94% NQ +22.78% |
| US09075V1026.SG | BioNTech SE (ADRs) | - | 3.80% | - | - | CY - CQ - NY - NQ - | CY - CQ - NY - NQ - |